Lv3
248 积分 2023-05-24 加入
Anti-CD19 CAR T cell therapy for refractory SLE-ITP
1个月前
已关闭
BCMA-CD19 Dual-Targeted CAR-T Cell Therapy for Relapsed or Refractory AL Amyloidosis
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
1个月前
已完结
Pharmacokinetics of acyclovir after intravenous and oral administration
1个月前
已完结
Acyclovir: Mechanism of Action, Pharmacokinetics, Safety and Clinical Applications
1个月前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
3个月前
已完结
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion
4个月前
已完结
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
4个月前
已完结
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
4个月前
已完结
皖公网安备34019202002308
